| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/15/2007 | CA2149922C Genetically engineered glutaminase and its use in antiviral and anticancer therapy |
| 05/15/2007 | CA2130452C Altered antibodies, products and processes relating thereto |
| 05/15/2007 | CA2087958C Transferrin binding proteins from neisseria gonorrhoeae and neisseria meningitidis |
| 05/15/2007 | CA2083259C Nucleotide sequence of soybean stearoyl-acp desaturase gene |
| 05/15/2007 | CA2071879C Glutamate receptor compositions and methods |
| 05/15/2007 | CA2065414C Treatment of autoimmune disease |
| 05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
| 05/10/2007 | WO2007053802A2 Drug and gene delivery by polymer nanonozzle and nanotip cell patch |
| 05/10/2007 | WO2007053781A2 Compositions with antigens adsorbed to calcium phosphate |
| 05/10/2007 | WO2007053718A1 Antibodies and immunotoxins that target human glycoprotein nmb |
| 05/10/2007 | WO2007053637A2 A tumor susceptible rat with a mutation in apc gene |
| 05/10/2007 | WO2007053489A2 Attenuated salmonella enterica serovar paratyphi a and uses thereof |
| 05/10/2007 | WO2007053207A2 Methods for controlling stem cell differentiation |
| 05/10/2007 | WO2007053184A2 Methods for producing micrornas |
| 05/10/2007 | WO2007053182A2 Plant produced vaccine for amebiasis |
| 05/10/2007 | WO2007052841A1 Platelet aggregation inhibitor composition |
| 05/10/2007 | WO2007052765A1 Rna extraction method and rna detection method |
| 05/10/2007 | WO2007052728A1 Method for improvement in transformation efficiency or homologous recombination efficiency in cell by using dna oligomer as carrier for gene delivery, and cell transformed using the method |
| 05/10/2007 | WO2007052689A1 Gene transfer agent and gene vector |
| 05/10/2007 | WO2007052629A1 Oligo double-stranded rna and pharmaceutical composition |
| 05/10/2007 | WO2007052466A1 Method of screening substance useful in treating disease with the use of gpr40 and phospholipase |
| 05/10/2007 | WO2007052398A1 Method of screening compound useful in treating allergic disease |
| 05/10/2007 | WO2007052376A1 Method for improving drought stress tolerance of plant using activated areb1 |
| 05/10/2007 | WO2007052101A1 Linear amplification of rna using a high-heel primer |
| 05/10/2007 | WO2007052046A1 Anti-hepatitis b virus ribozymal nucleic acid |
| 05/10/2007 | WO2007052029A1 Oncolytic herpes virus vectors |
| 05/10/2007 | WO2007051898A1 Alternative oxidase and uses thereof |
| 05/10/2007 | WO2007051866A2 Plants having improved growth characteristics and a method for making the same |
| 05/10/2007 | WO2007051864A1 Method for selectively and reversibly adsorbing nucleic acids on a carrier material |
| 05/10/2007 | WO2007051832A1 Means and methods to modulate flavonoid biosynthesis in plants and plant cells |
| 05/10/2007 | WO2007051781A1 Novel cxc-chemokine antagonists |
| 05/10/2007 | WO2007051725A2 Microorganism and process for the preparation of l-methionine |
| 05/10/2007 | WO2007051651A1 INDUSTRIAL PRODUCING STRAIN OF THE FUNGUS CLAVICEPS PURPUREA (Fr.) Tul. |
| 05/10/2007 | WO2007051642A1 Method for increasing the total oil content in oil plants |
| 05/10/2007 | WO2007051626A2 Disease resistant plants |
| 05/10/2007 | WO2007051623A1 Affiphores, their isolation and use |
| 05/10/2007 | WO2007051577A2 METHOD FOR THE PRODUCTION OF γ-LINOLENIC ACID AND/OR STEARIDONIC ACID IN TRANSGENIC BRASSICACEAE AND LINACEAE |
| 05/10/2007 | WO2007051483A1 Disease resistant plants |
| 05/10/2007 | WO2007051355A1 The use of recombinant d-amino acid oxidase |
| 05/10/2007 | WO2007051316A1 Inhibition of autophagy genes in cancer chemotherapy |
| 05/10/2007 | WO2007051271A2 Construction of recombinant adenovirus with genes that codify for sag1, sag2 and sag3 |
| 05/10/2007 | WO2007051267A2 Method for the production of recombinant virus, dna constructs, recombinant virus and vaccine compositions |
| 05/10/2007 | WO2007035962A3 Gene blocking method |
| 05/10/2007 | WO2007031493A3 A new selection system for wheat |
| 05/10/2007 | WO2007028239A3 Dna sequences involved in prenylflavonoid biosynthesis in hops and their use in modifying prenylflavonoid production in plants |
| 05/10/2007 | WO2007026049A3 Improved method for fermentation by repairing yeast genes |
| 05/10/2007 | WO2007017419A3 Method for producing arachidonic acid and/or eicosapentaenoic acid in useful transgenic plants |
| 05/10/2007 | WO2007014971A3 Genes involved in the biosynthesis of thiocoraline and heterologous production of same |
| 05/10/2007 | WO2007014169A3 Anti-cd26 antibodies and methods of use thereof |
| 05/10/2007 | WO2007005620A3 Arginase ii: a target treatment of aging heart and heart failure |
| 05/10/2007 | WO2007004062A3 Tetracycline-dependent regulation of rna interference |
| 05/10/2007 | WO2007002096A3 Methods and compositions for targeting ifnar2 |
| 05/10/2007 | WO2006135434A3 Semi-soft c-class immunostimulatory oligonucleotides |
| 05/10/2007 | WO2006134125A9 Antigen conjugates and uses thereof |
| 05/10/2007 | WO2006133257A9 Use of cis-epoxyeicosatrienoic acids and inhibitors of soluble epoxide hydrolase to reduce cardiomyopathy |
| 05/10/2007 | WO2006133148A3 Method of producing antibodies with modified fucosylation level |
| 05/10/2007 | WO2006131512A3 Anti-thrombotic agents |
| 05/10/2007 | WO2006126982A3 Nuclease resistant external guide sequences for treating inflammatory and viral related respiratory diseases |
| 05/10/2007 | WO2006122828A3 Optimized injection formulation for rna |
| 05/10/2007 | WO2006113085A3 D-amino acid dehydrogenase and method of making d-amino acids |
| 05/10/2007 | WO2006105597A8 Variants of hepatitis b virus with resistance to anti-viral nucleoside agents and applications thereof |
| 05/10/2007 | WO2006102395A3 Delivery systems and methods for diagnosing and treating cardiovascular diseases |
| 05/10/2007 | WO2006098626A3 Resistance against parasitic weeds |
| 05/10/2007 | WO2006091090A3 The use of cell implants in bladder and gut of non-human animals for the production of peptides |
| 05/10/2007 | WO2006070227A3 Method for down-regulating gene expression in fungi |
| 05/10/2007 | WO2006047242A3 Duffy antigen receptor for chemokines and use thereof |
| 05/10/2007 | WO2006044290A8 Biosynthesis of philoroglucinol and preparation of 1,3-dihydroxybenzene therefrom |
| 05/10/2007 | WO2006007124A3 Nucleic acid sequences encoding cel ii endonuclease |
| 05/10/2007 | WO2005113776A3 Expression cassette |
| 05/10/2007 | WO2005102034A3 Regulatory sequences for expressing gene products in plant reproductive tissue |
| 05/10/2007 | WO2005049788A3 Reprogramming of somatic cell nuclei |
| 05/10/2007 | WO2004060910A3 Bioactive peptides and unique ires elements from myelin proteolipid protein plp/dm20 |
| 05/10/2007 | US20070107087 Use of early light-inducible proteins (elip) to increase plant resistance to photochemical oxidant stress |
| 05/10/2007 | US20070107086 NT-1 plant cell line stably transformed to express a transgene encoding a proteinaceous vaccine antigen; does not support growth of Mycoplasmataceae; contains no materials of animal origin; Potassium Phosphate, Dibasic, Sucrose, Batch Salts; consistent transgene expression recovered from cryopreservation |
| 05/10/2007 | US20070107085 Process for proteolytic cleavage and purification of recombinant proteins produced in plants |
| 05/10/2007 | US20070107084 Dof (DNA binding with one finger) sequences and methods of use |
| 05/10/2007 | US20070107083 Method for regulating plant growth |
| 05/10/2007 | US20070107082 Transgenic monocotyledonous plants overexpressing a nhx protein and having improved growth characteristics and a method for making the same |
| 05/10/2007 | US20070107081 Generating cyclyzed triterpenes in soybean for treatment and prevention of high blood cholesterol and heart disease |
| 05/10/2007 | US20070107079 Plant cell death system |
| 05/10/2007 | US20070107078 Methods to confer herbicide resistance |
| 05/10/2007 | US20070107077 Microprojectile bombardment transformation of brassica |
| 05/10/2007 | US20070107076 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo |
| 05/10/2007 | US20070107075 Disruptions in GABA Receptor RHO2 Subunit, Methods and Uses Thereof |
| 05/10/2007 | US20070107074 Porcine Nuclear Transfer |
| 05/10/2007 | US20070107072 Transgenic amphibian models for lymphatic vessel development |
| 05/10/2007 | US20070107071 Use of regulatory sequences for specific, transient expression in neuronal determined cells |
| 05/10/2007 | US20070107070 Invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 05/10/2007 | US20070107069 Animal model having a chimeric human liver |
| 05/10/2007 | US20070106070 T cell costimulatory molecule genes; used to identify components of the signal transduction pathway induced in a cell |
| 05/10/2007 | US20070106069 Non-Human Primate Fc Receptors and Methods of Use |
| 05/10/2007 | US20070106068 Nucleotide sequences coding Zcytor16 specific immunoglobulin for use in prevention and treatment of nervous system, inflammatory and autoimmune disorders |
| 05/10/2007 | US20070106067 Assay kit and antibody for human low molecular weight cd14 |
| 05/10/2007 | US20070106066 Cherkasky fusion proteins containing antibody-, antigen- and microtubule-binding regions and immune response-triggering regions |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105809 Modulators of coagulation factors with enhanced stability |
| 05/10/2007 | US20070105808 Inhibition of histone deacetylase |
| 05/10/2007 | US20070105807 capable of altering the splicing of a pre-mRNA encoding said receptor to increase production of a stable, secreted, ligand-binding form of the receptor; arthritis, juvenile rheumatoid arthritis, psoriasis, psoriatic arthritis, ankylosing spondylitis, inflammatory bowel disease, hepatitis, sepsis |
| 05/10/2007 | US20070105806 Administering to a patient in needs of treatment, prevention or management of neuropathic pain, a therapeutically or prophylactically effective amount of a double-stranded RNA (dsRNA), consists of a sense strand and an antisense strand that are complementary to each other |
| 05/10/2007 | US20070105804 Drug delivery of polynucleotide to primate hepatocyte; high level of gene expression with transient increases in liver enzymes |